Literature DB >> 25512793

Sirtuins as novel players in the pathogenesis of diabetes mellitus.

Kultigin Turkmen1, Ali Karagoz1, Adem Kucuk1.   

Abstract

Diabetes mellitus (DM) is a systemic and complex disease with micro and macrovascular complications that result from impaired metabolic pathways and genetic susceptibilities. DM has been accepted as an epidemic worldwide during the last two decades. A substantial gap in our knowledge exists regarding the pathophysiology of this metabolic disorder despite the improved diagnostic tools and therapeutic approaches. Sirtuins are a group of NAD(+) dependent enzymes that are involved in cellular homeostasis due to their deacetylating activity. In the present review, we aimed to discuss the role of associated sirtuins in the pathogenesis and treatment of diabetes mellitus.

Entities:  

Keywords:  Diabetes mellitus; Hyperglycemia; Hyperlipidemia; Resveratrol; Sirtuins

Year:  2014        PMID: 25512793      PMCID: PMC4265877          DOI: 10.4239/wjd.v5.i6.894

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  72 in total

1.  SIRT6 promotes DNA repair under stress by activating PARP1.

Authors:  Zhiyong Mao; Christopher Hine; Xiao Tian; Michael Van Meter; Matthew Au; Amita Vaidya; Andrei Seluanov; Vera Gorbunova
Journal:  Science       Date:  2011-06-17       Impact factor: 47.728

Review 2.  Nephroprotective action of sirtuin 1 (SIRT1).

Authors:  Dorota Polak-Jonkisz; Krystyna Laszki-Szcząchor; Leopold Rehan; Witold Pilecki; Henryk Filipowski; Małgorzata Sobieszczańska
Journal:  J Physiol Biochem       Date:  2013-06-23       Impact factor: 4.158

3.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

Authors:  Joseph T Rodgers; Carlos Lerin; Wilhelm Haas; Steven P Gygi; Bruce M Spiegelman; Pere Puigserver
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

4.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

Review 5.  NAD+ and vitamin B3: from metabolism to therapies.

Authors:  Anthony A Sauve
Journal:  J Pharmacol Exp Ther       Date:  2007-12-28       Impact factor: 4.030

6.  Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo.

Authors:  Hiroshi Inoue; Wataru Ogawa; Michitaka Ozaki; Sanae Haga; Michihiro Matsumoto; Kensuke Furukawa; Naoko Hashimoto; Yoshiaki Kido; Toshiyuki Mori; Hiroshi Sakaue; Kiyoshi Teshigawara; Shiyu Jin; Haruhisa Iguchi; Ryuji Hiramatsu; Derek LeRoith; Kiyoshi Takeda; Shizuo Akira; Masato Kasuga
Journal:  Nat Med       Date:  2004-01-11       Impact factor: 53.440

Review 7.  The Sir2 family of protein deacetylases.

Authors:  Gil Blander; Leonard Guarente
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

8.  The direct involvement of SirT1 in insulin-induced insulin receptor substrate-2 tyrosine phosphorylation.

Authors:  Jiandi Zhang
Journal:  J Biol Chem       Date:  2007-09-27       Impact factor: 5.157

9.  Distinct pathways of insulin-regulated versus diabetes-regulated gene expression: an in vivo analysis in MIRKO mice.

Authors:  Vijay K Yechoor; Mary-Elizabeth Patti; Kohjiro Ueki; Palle G Laustsen; Robert Saccone; Ravi Rauniyar; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-16       Impact factor: 11.205

10.  Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells.

Authors:  Laura Bordone; Maria Carla Motta; Frederic Picard; Ashley Robinson; Ulupi S Jhala; Javier Apfeld; Thomas McDonagh; Madeleine Lemieux; Michael McBurney; Akos Szilvasi; Erin J Easlon; Su-Ju Lin; Leonard Guarente
Journal:  PLoS Biol       Date:  2005-12-27       Impact factor: 8.029

View more
  23 in total

1.  The absence of SIRT3 and SIRT5 promotes the acetylation of lens proteins and improves the chaperone activity of α-crystallin in mouse lenses.

Authors:  Sandip K Nandi; Rooban B Nahomi; Peter S Harris; Cole R Michel; Kristofer S Fritz; Ram H Nagaraj
Journal:  Exp Eye Res       Date:  2019-03-05       Impact factor: 3.467

2.  Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy.

Authors:  Vemana Gowd; Qingzheng Kang; Qi Wang; Qiang Wang; Feng Chen; Ka-Wing Cheng
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

Review 3.  Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies.

Authors:  Jasvinder Singh Bhatti; Gurjit Kaur Bhatti; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-11-09       Impact factor: 5.187

Review 4.  Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious Diseases.

Authors:  Robert N Mahon; Richard Hafner
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

Review 5.  Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity.

Authors:  Xiaoting Luo; Jinzi Wu; Siqun Jing; Liang-Jun Yan
Journal:  Aging Dis       Date:  2016-01-02       Impact factor: 6.745

Review 6.  Sources and implications of NADH/NAD(+) redox imbalance in diabetes and its complications.

Authors:  Jinzi Wu; Zhen Jin; Hong Zheng; Liang-Jun Yan
Journal:  Diabetes Metab Syndr Obes       Date:  2016-05-10       Impact factor: 3.168

7.  Redox imbalance and mitochondrial abnormalities in the diabetic lung.

Authors:  Jinzi Wu; Zhen Jin; Liang-Jun Yan
Journal:  Redox Biol       Date:  2016-11-17       Impact factor: 11.799

Review 8.  Antidiabetic Effects of Resveratrol: The Way Forward in Its Clinical Utility.

Authors:  Omolola R Oyenihi; Ayodeji B Oyenihi; Anne A Adeyanju; Oluwafemi O Oguntibeju
Journal:  J Diabetes Res       Date:  2016-12-05       Impact factor: 4.011

9.  Melatonin Attenuates Diabetic Myocardial Microvascular Injury through Activating the AMPK/SIRT1 Signaling Pathway.

Authors:  Bin Wang; Jinyu Li; Mi Bao; Runji Chen; Haiyan Li; Binger Lu; Meixin Chen; Danmei Huang; Yanmei Zhang; Fenfei Gao; Ganggang Shi
Journal:  Oxid Med Cell Longev       Date:  2021-05-27       Impact factor: 6.543

Review 10.  Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications.

Authors:  Hong Zheng; Jinzi Wu; Zhen Jin; Liang-Jun Yan
Journal:  Biochem Insights       Date:  2016-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.